AnnouncedFiled 11 May 2026
Syncromune, Inc. has sold $145M so far
Syncromune, Inc., a biotech company based in Fort Lauderdale, FL, has sold $145M so far in its equity round, according to a filing dated 11 May 2026.
Announced on 20 December 2024, 507 days before the filing. endpoints.news ↗
- Filed
- 11 May 2026
- First filed
- 17 December 2024
- Round
- Equity round (amended filing)
- Amount sold
- $145M
- Offering size
- $145M
- Investors so far
- 77
- Based in
- Fort Lauderdale, FL
- Industry
- Biotech
- Website
- syncromune.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 94% of the 845 tracked raises with an amount filed in 2026, and than 99% of the 78 in biotech.
Syncromune, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 11 May 2026 | Amended filing | $145M | This raise |
| 21 Aug 2025 | Amended filing | $112M | This raise |
| 17 Dec 2024 | New filing | $50.8M | This raise |
| 6 Oct 2023 | Amended filing | $14.2M | Another raise |
| 29 Nov 2022 | New filing | $5.31M | Another raise |
More with Measured Fund on the board
- ImmunSYS, Inc.$283K
- Accelerated Pharma, Inc.$250K
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.